Company Overview
Position Overview
The Executive Director, Investor Relations will serve as the primary point of contact for the investment community and play a critical role in shaping Immunome’s external communications strategy. Reporting to the Chief Financial Officer, this leader will be responsible for articulating the company’s strategy, progress, and value proposition to investors, analysts, and other key financial stakeholders. The role requires deep understanding of the biotechnology sector and the ability to translate complex scientific and clinical information into clear, compelling narratives that enhance Immunome’s visibility and credibility in the capital markets.
Responsibilities
Investor Relations
- Execute the investor relations program in partnership with the CEO and CFO, ensuring clear, consistent, and disciplined communication with the capital markets.
- Own day-to-day IR execution, including investor and analyst meeting coordination, targeting support, CRM management, feedback capture, and follow-up.
- Draft all core IR materials, including investor presentations, fact sheets, FAQs, earnings scripts, Q&A documents, and conference talk tracks.
- Serve as the primary point of contact for sell-side analysts on logistics and clarifications; proactively identify and correct misinterpretations.
- Coordinate investor conferences, non-deal roadshows, and other capital markets engagements.
- Track, synthesize, and report investor sentiment and market feedback to senior management and the Board.
Corporate Communications
- Lead execution of the corporate communications function, with direct responsibility for drafting press releases, corporate updates, pipeline and clinical announcements, and reactive statements.
- Translate complex scientific, clinical, and regulatory information into clear, accurate, and investable external messaging.
- Partner closely with Legal and senior management to ensure Reg FD compliance, disclosure discipline, and appropriate risk framing.
- Manage PR and IR agencies, setting direction and maintaining a high bar for accuracy, clarity, and quality.
- Support media engagement and spokesperson preparation; manage inbound media inquiries as needed.
- Ensure consistency across all external-facing materials and channels.
Cross-functional leadership
- Serve as the central point of coordination for external messaging across Finance, Clinical, Regulatory, Legal, and Business Development.
- Own the external communications calendar and disclosure cadence.
- Identify communication risks early and escalate judgment calls appropriately.
- Support special situations, including clinical data releases, financings, and issues management.
Qualifications
- A minimum of 10 years of experience in investor relations, corporate communications, or a closely related role within biotech, biopharma, or life sciences.
- Public company experience, including direct involvement in earnings preparation and material disclosures.
- Demonstrated ability to independently draft high-quality press releases, investor materials, and executive-level communications.
- Strong scientific literacy, with the ability to understand and accurately communicate clinical data and development strategy.
- Strong financial literacy and comfort engaging with analysts, investors, and capital markets topics.
- Experience working closely with senior executives and serving as a trusted execution partner.
- Experience managing external agencies (IR, PR, communications).
- Bachelor’s degree required; advanced degree a plus.
Knowledge and Skills
- Exceptional written and verbal communication skills, with a proven ability to translate complex scientific and financial information into clear, disciplined external messaging.
- Deep understanding of biotech sector dynamics and public equity markets.
- Sound judgment around disclosure, tone, timing, and risk; effective in high-stakes, fast-moving situations.
- Strong analytical, strategic thinking, and presentation skills.
- Ability to operate effectively in a fast-paced, high-growth environment while maintaining precision, professionalism, and confidentiality.
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Skills Required
- Minimum of 10 years of experience in investor relations, corporate communications, or closely related role in biotech, biopharma, or life sciences
- Public company experience including earnings preparation and disclosures
- Ability to draft high-quality press releases and investor materials
- Strong scientific literacy to understand and communicate clinical data
- Strong financial literacy and comfort engaging with analysts
- Experience managing external agencies (IR, PR, communications)
- Bachelor's degree required; advanced degree preferred
What We Do
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
